Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Internal Medicine | Nursing | Pharmacy | Anesthesiology & Pain | Journal

Back to Journal Articles

Intranasal Oxytocin Application Enhances Placebo Effect

Last Updated: October 22, 2013.

 

Oxytocin may enhance placebo through effect of trust, empathy of administering physician

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Intranasal application of the hormone oxytocin enhances the placebo response, according to a research letter published in the Oct. 23/30 issue of the Journal of the American Medical Association.

TUESDAY, Oct. 22 (HealthDay News) -- Intranasal application of the hormone oxytocin enhances the placebo response, according to a research letter published in the Oct. 23/30 issue of the Journal of the American Medical Association.

Simon Kessner, from the University Medical Center Hamburg-Eppendorf in Germany, and colleagues recruited 75 healthy male volunteers who were randomly assigned to receive 40 IU of oxytocin (37 participants) or saline intranasally. After 45 minutes, two identical inert ointments were applied to two sites on each participant's forearm, although one was described as an anesthetic. A calibration procedure identified the individual stimulation intensity at which a 20-second painful heat stimulus was perceived as a 60 on a visual analogue scale (VAS; ranging from 0 [no pain] to 100 [unbearable pain]).

The researchers found that pain ratings for the placebo site were significantly lower compared with the control site across both treatment groups, despite identical thermal stimulation. In the oxytocin group, the placebo analgesic response was significantly higher compared to the saline group. There were no significant differences between the groups related to temperature levels needed to induce a VAS score of 60, pain ratings on the control site, adverse effects, and post hoc treatment guesses, thus, consistent with oxytocin having no analgesic effect.

"To our knowledge, our study provides the first experimental evidence that placebo responses can be pharmacologically enhanced by the application of intranasal oxytocin," the authors write. "Based on its effects on trust and empathy, we hypothesize that oxytocin might have increased the believability of the instructions by the study physician."

One author disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Copyright © 2013 HealthDay. All rights reserved.


Previous: Anti-Obesity Messages May Inadvertantly Up Eating Disorders Next: Modest Survival Benefits Seen for Family Caregivers

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.